Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$72.55
-1.11-1.51%
At close: -
$72.55
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
Globus Medical Analyst Ratings and Price Targets | NYSE:GMED | Benzinga
Globus Medical Inc has a consensus price target of $89.56 based on the ratings of 19 analysts. The high is $115 issued by Roth MKM on December 17, 2024. The low is $70 issued by Loop Capital on February 10, 2023. The 3 most-recent analyst ratings were released by Truist Securities, Barclays, and Stifel on March 18, 2025, February 24, 2025, and February 21, 2025, respectively. With an average price target of $93 between Truist Securities, Barclays, and Stifel, there's an implied 28.19% upside for Globus Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Barclays
Stifel
Wells Fargo
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Globus Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | Buy Now | 13.03% | Truist Securities | Richard Newitter74% | $90 → $82 | Maintains | Hold | Get Alert |
| 03/18/2025 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | Hold → Hold | Get Alert |
| 02/24/2025 | Buy Now | — | Citizens Capital Markets | David Turkaly53% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/24/2025 | Buy Now | 41.97% | Barclays | Matt Miksic67% | $100 → $103 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | 29.57% | Stifel | Mathew Blackman61% | $92 → $94 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 28.19% | Wells Fargo | Vik Chopra44% | $95 → $93 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | Hold → Hold | Get Alert |
| 02/06/2025 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | Hold → Hold | Get Alert |
| 01/10/2025 | Buy Now | 39.21% | Canaccord Genuity | William Plovanic58% | $92 → $101 | Maintains | Buy | Get Alert |
| 01/09/2025 | Buy Now | 33.7% | B of A Securities | Craig Bijou74% | $80 → $97 | Upgrade | Underperform → Neutral | Get Alert |
| 01/09/2025 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | Hold → Hold | Get Alert |
| 12/18/2024 | Buy Now | 24.05% | Truist Securities | Richard Newitter74% | $85 → $90 | Maintains | Hold | Get Alert |
| 12/17/2024 | Buy Now | 58.51% | Roth MKM | Jason Wittes53% | $100 → $115 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 25.43% | BTIG | Ryan Zimmerman73% | $87 → $91 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 30.94% | Wells Fargo | Vik Chopra44% | $88 → $95 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 26.81% | Canaccord Genuity | William Plovanic58% | $85 → $92 | Maintains | Buy | Get Alert |
| 12/02/2024 | Buy Now | 37.84% | Morgan Stanley | Drew Ranieri45% | $83 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/11/2024 | Buy Now | 14.4% | Morgan Stanley | Drew Ranieri45% | $74 → $83 | Maintains | Equal-Weight | Get Alert |
| 11/07/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 11/06/2024 | Buy Now | 26.81% | Stifel | Mathew Blackman61% | $80 → $92 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 17.16% | Canaccord Genuity | William Plovanic58% | $79 → $85 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 37.84% | Roth MKM | Jason Wittes53% | $100 → $100 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2024 | Buy Now | 26.81% | RBC Capital | Shagun Singh57% | $80 → $92 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 21.3% | Wells Fargo | Vik Chopra44% | $78 → $88 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 37.84% | Piper Sandler | Matt O'Brien51% | $80 → $100 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | 10.27% | B of A Securities | Craig Bijou74% | $55 → $80 | Maintains | Underperform | Get Alert |
| 11/06/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 10/14/2024 | Buy Now | 7.51% | BTIG | Ryan Zimmerman73% | $77 → $78 | Maintains | Buy | Get Alert |
| 10/08/2024 | Buy Now | 10.27% | RBC Capital | Shagun Singh57% | $78 → $80 | Maintains | Outperform | Get Alert |
| 08/28/2024 | Buy Now | 6.13% | BTIG | Ryan Zimmerman73% | $75 → $77 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 28.19% | Barclays | Matt Miksic67% | $85 → $93 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | 7.51% | RBC Capital | Shagun Singh57% | $76 → $78 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | 8.89% | Truist Securities | Richard Newitter74% | $78 → $79 | Maintains | Hold | Get Alert |
| 08/07/2024 | Buy Now | 7.51% | Wells Fargo | Vik Chopra44% | $60 → $78 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/07/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 07/16/2024 | Buy Now | 7.51% | Truist Securities | Richard Newitter74% | $63 → $78 | Maintains | Hold | Get Alert |
| 07/15/2024 | Buy Now | 3.38% | BTIG | Ryan Zimmerman73% | $72 → $75 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | -2.14% | Morgan Stanley | Drew Ranieri45% | $67 → $71 | Maintains | Equal-Weight | Get Alert |
| 05/29/2024 | Buy Now | -0.76% | BTIG | Ryan Zimmerman73% | $63 → $72 | Maintains | Buy | Get Alert |
| 05/20/2024 | Buy Now | 10.27% | Piper Sandler | Matt O'Brien51% | $60 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 05/09/2024 | Buy Now | 17.16% | Barclays | Matt Miksic67% | $83 → $85 | Maintains | Overweight | Get Alert |
| 05/08/2024 | Buy Now | -13.16% | BTIG | Ryan Zimmerman73% | $60 → $63 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | -17.3% | Piper Sandler | Matt O'Brien51% | $55 → $60 | Maintains | Neutral | Get Alert |
| 05/08/2024 | Buy Now | -3.51% | Stifel | Mathew Blackman61% | $64 → $70 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | — | Needham | David Saxon54% | — | Reiterates | → Hold | Get Alert |
| 03/18/2024 | Buy Now | -17.3% | BTIG | Ryan Zimmerman73% | → $60 | Upgrade | Neutral → Buy | Get Alert |
| 02/21/2024 | Buy Now | 8.89% | Canaccord Genuity | Caitlin Cronin49% | → $79 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | Buy Now | -17.3% | Truist Securities | Richard Newitter74% | $58 → $60 | Maintains | Hold | Get Alert |
| 01/11/2024 | Buy Now | -3.51% | RBC Capital | Shagun Singh57% | $70 → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 12/22/2023 | Buy Now | -20.06% | Truist Securities | Richard Newitter74% | $53 → $58 | Maintains | Hold | Get Alert |
| 12/20/2023 | Buy Now | -2.14% | Canaccord Genuity | Kyle Rose66% | $67 → $71 | Maintains | Buy | Get Alert |
| 11/14/2023 | Buy Now | -26.95% | Morgan Stanley | Drew Ranieri45% | $60 → $53 | Maintains | Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | -26.95% | Truist Securities | Richard Newitter74% | $58 → $53 | Maintains | Hold | Get Alert |
| 10/20/2023 | Buy Now | 3.38% | Roth MKM | Jason Wittes53% | → $75 | Initiates | → Buy | Get Alert |
| 10/12/2023 | Buy Now | 18.54% | Barclays | Matt Miksic67% | $77 → $86 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | -15.92% | Stifel | Mathew Blackman61% | → $61 | Upgrade | Hold → Buy | Get Alert |
| 09/15/2023 | Buy Now | -20.06% | Wells Fargo | Vik Chopra44% | $63 → $58 | Maintains | Equal-Weight | Get Alert |
| 09/05/2023 | Buy Now | -10.41% | Truist Securities | Richard Newitter74% | → $65 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | Buy Now | -10.41% | Truist Securities | Richard Newitter74% | $68 → $65 | Maintains | Hold | Get Alert |
| 08/07/2023 | Buy Now | 6.13% | Barclays | Matt Miksic67% | $75 → $77 | Maintains | Overweight | Get Alert |
| 08/04/2023 | Buy Now | -13.16% | Wells Fargo | Vik Chopra44% | $61 → $63 | Maintains | Equal-Weight | Get Alert |
| 07/19/2023 | Buy Now | -6.27% | Truist Securities | Richard Newitter74% | $64 → $68 | Maintains | Hold | Get Alert |
| 05/31/2023 | Buy Now | -17.3% | Morgan Stanley | Drew Ranieri45% | $64 → $60 | Maintains | Equal-Weight | Get Alert |
| 05/24/2023 | Buy Now | — | JMP Securities | David Turkaly53% | — | Reiterates | → Market Perform | Get Alert |
| 05/05/2023 | Buy Now | -11.78% | Truist Securities | Richard Newitter74% | $66 → $64 | Maintains | Hold | Get Alert |
| 03/30/2023 | Buy Now | -7.65% | Canaccord Genuity | Kyle Rose66% | → $67 | Upgrade | Hold → Buy | Get Alert |
| 03/28/2023 | Buy Now | -7.65% | Canaccord Genuity | Kyle Rose66% | → $67 | Reiterates | → Hold | Get Alert |
| 02/22/2023 | Buy Now | -11.78% | Morgan Stanley | Drew Ranieri45% | $78 → $64 | Maintains | Equal-Weight | Get Alert |
| 02/22/2023 | Buy Now | -7.65% | Canaccord Genuity | Kyle Rose66% | $75 → $67 | Maintains | Hold | Get Alert |
| 02/22/2023 | Buy Now | -15.92% | Wells Fargo | Vik Chopra44% | $67 → $61 | Maintains | Equal-Weight | Get Alert |
| 02/13/2023 | Buy Now | -13.16% | B of A Securities | Craig Bijou74% | $83 → $63 | Downgrade | Buy → Underperform | Get Alert |
| 02/10/2023 | Buy Now | -7.65% | Wells Fargo | Vik Chopra44% | $82 → $67 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | -3.51% | Truist Securities | Richard Newitter74% | → $70 | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | -3.51% | Loop Capital | Jason Wittes53% | $90 → $70 | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | — | Needham | David Saxon54% | — | Downgrade | Buy → Hold | Get Alert |
| 02/10/2023 | Buy Now | — | BTIG | Ryan Zimmerman73% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/09/2023 | Buy Now | — | Piper Sandler | Matt O'Brien51% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/06/2023 | Buy Now | 7.51% | Morgan Stanley | Drew Ranieri45% | $68 → $78 | Maintains | Equal-Weight | Get Alert |
| 12/20/2022 | Buy Now | 17.16% | Truist Securities | Richard Newitter74% | $74 → $85 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | 13.03% | Wells Fargo | Vik Chopra44% | $74 → $82 | Maintains | Overweight | Get Alert |
| 11/09/2022 | Buy Now | -6.27% | Morgan Stanley | Drew Ranieri45% | $66 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | -4.89% | Barclays | Matt Miksic67% | → $69 | Initiates | → Overweight | Get Alert |
| 10/12/2022 | Buy Now | 3.38% | Jefferies | Matthew Taylor67% | → $75 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | -9.03% | Morgan Stanley | Drew Ranieri45% | $62 → $66 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | Buy Now | 3.38% | Piper Sandler | Matt O'Brien51% | $80 → $75 | Maintains | Overweight | Get Alert |
| 07/20/2022 | Buy Now | -2.14% | Truist Securities | Richard Newitter74% | $76 → $71 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | -14.54% | Morgan Stanley | Drew Ranieri45% | $68 → $62 | Maintains | Equal-Weight | Get Alert |
| 05/12/2022 | Buy Now | -6.27% | Morgan Stanley | Drew Ranieri45% | $74 → $68 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | Buy Now | 0.62% | RBC Capital | Shagun Singh57% | $78 → $73 | Maintains | Outperform | Get Alert |
| 05/11/2022 | Buy Now | -3.51% | Wells Fargo | Larry Biegelsen69% | $80 → $70 | Maintains | Overweight | Get Alert |
| 05/11/2022 | Buy Now | -2.14% | Needham | David Saxon54% | $76 → $71 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Globus Medical (GMED) stock?
The latest price target for Globus Medical (NYSE:GMED) was reported by Truist Securities on March 18, 2025. The analyst firm set a price target for $82.00 expecting GMED to rise to within 12 months (a possible 13.03% upside). 45 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Globus Medical (GMED)?
The latest analyst rating for Globus Medical (NYSE:GMED) was provided by Truist Securities, and Globus Medical maintained their hold rating.
When was the last upgrade for Globus Medical (GMED)?
The last upgrade for Globus Medical Inc happened on January 9, 2025 when B of A Securities raised their price target to $97. B of A Securities previously had an underperform for Globus Medical Inc.
When was the last downgrade for Globus Medical (GMED)?
The last downgrade for Globus Medical Inc happened on February 13, 2023 when B of A Securities changed their price target from $83 to $63 for Globus Medical Inc.
When is the next analyst rating going to be posted or updated for Globus Medical (GMED)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Globus Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Globus Medical was filed on March 18, 2025 so you should expect the next rating to be made available sometime around March 18, 2026.
Is the Analyst Rating Globus Medical (GMED) correct?
While ratings are subjective and will change, the latest Globus Medical (GMED) rating was a maintained with a price target of $90.00 to $82.00. The current price Globus Medical (GMED) is trading at is $72.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.